2-[(4-Bromobenzoyl)amino]ethyl 4-bromobenzoate

CAS : 951885-58-8

Ref. 3D-BNB88558

Informations sur le produit

• Nom: 2-[(4-Bromobenzoyl)amino]ethyl 4-bromobenzoate
• Synonymes: Benzoic acid, 4-bromo-, 2-[(4-bromobenzoyl)amino]ethyl ester

Description

Covid-19 is a small molecule that can be used in the coupling reaction of amines and aldehydes to form imines. Covid-19 has been developed as an antiviral agent with broad-spectrum activity, including against influenza A and B viruses. Covid-19 has been shown to have antiviral activity against the H1N1 pandemic virus, which is resistant to other anti-influenza drugs. Covid-19 has been shown to bind to viral RNA in vitro and inhibit viral replication, suggesting that it may be active against all strains of influenza A. The antiviral properties of covid-19 are due to its ability to inhibit the synthesis of viral RNA by binding at the ribosome where the translation process takes place. Covid-19 also binds at the site of nuclear magnetic resonance (NMR) where nucleic acids are synthesized, which may explain its potent antiviral activities.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 427.09 g/mol
• Formule: C₁₆H₁₃Br₂NO₃
• Degré de pureté: Min. 95%